Also trades as: OACCW (NASDAQ) · $vol 0M
OACC NASDAQ
Oaktree Acquisition Corp. II
1W: +0.0%
1M: +0.1%
3M: +0.3%
YTD: +0.8%
1Y: +2.3%
$10.74
+0.03 (+0.28%)
Weekly Expected Move ±0.4%
$11
$11
$11
$11
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$264.0M
52W Range10.3-10.75
Volume178,751
Avg Volume11,665
Beta-0.04
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZaid Pardesi
Employees3
SectorFinancial Services
IndustryShell Companies
IPO Date2024-12-16
333 South Grand Avenue
Los Angeles, CA 90071
US
Los Angeles, CA 90071
US
213 830 6300
About Oaktree Acquisition Corp. II
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Martinez George Arth | 0 | — | 2025-10-29 | |
| BERRY DAVID A | 0 | — | 2025-10-17 | |
| Sweeney Thomas | 0 | — | 2025-06-03 | |
| Oaktree Acquisition | J-Other | 231,492 | — | 2024-10-30 |
| Oaktree Acquisition | C-Conversion | 33,981 | $10.00 | 2024-10-30 |